Materials • Major Chemicals
$131.53 ▼ -0.06
(-0.05%)
MKT CAP: $5.60B • VOL: 434.8K
52W L $83 52W H $139
SXT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.61B | $1.56B | $1.46B |
| YoY Revenue Growth % | +3.5% | +6.9% | — |
| Gross Profit | $539.3M | $507.1M | $640.8M |
| Gross Margin % | 33.5% | 32.6% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $207.1M | $191.6M | $155.0M |
| Operating Margin % | 12.8% | 12.3% | 10.6% |
| Net Income (GAAP) | $134.5M | $124.7M | $93.4M |
| EBITDA (Normalized) | $278.7M | $238.9M | $207.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $127.8M | $157.2M | $169.7M |
| Capital Expenditures (CapEx) | $89.4M | $59.2M | $65.5M |
| Free Cash Flow (FCF) | $38.4M | $97.9M | $104.2M |
| FCF Margin % | 2.4% | 6.3% | 7.2% |
| Return on Invested Capital (ROIC %) | 8.8% | 9.2% | 6.6% |
| Cash & Short-Term Equivalents | $36.5M | $26.6M | $338.7M |
| Total Debt (Short + Long Term) | $709.2M | $613.5M | $720.5M |
| Total Stockholders' Equity | $1.19B | $1.06B | $1.48B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SXT.